1. Home
  2. VSTS vs BCYC Comparison

VSTS vs BCYC Comparison

Compare VSTS & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTS
  • BCYC
  • Stock Information
  • Founded
  • VSTS 1936
  • BCYC 2009
  • Country
  • VSTS United States
  • BCYC United Kingdom
  • Employees
  • VSTS N/A
  • BCYC N/A
  • Industry
  • VSTS
  • BCYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSTS
  • BCYC Health Care
  • Exchange
  • VSTS Nasdaq
  • BCYC Nasdaq
  • Market Cap
  • VSTS 572.2M
  • BCYC 565.5M
  • IPO Year
  • VSTS N/A
  • BCYC 2019
  • Fundamental
  • Price
  • VSTS $5.30
  • BCYC $6.17
  • Analyst Decision
  • VSTS Sell
  • BCYC Buy
  • Analyst Count
  • VSTS 4
  • BCYC 11
  • Target Price
  • VSTS $9.13
  • BCYC $20.73
  • AVG Volume (30 Days)
  • VSTS 2.0M
  • BCYC 324.0K
  • Earning Date
  • VSTS 11-20-2025
  • BCYC 10-30-2025
  • Dividend Yield
  • VSTS 1.32%
  • BCYC N/A
  • EPS Growth
  • VSTS N/A
  • BCYC N/A
  • EPS
  • VSTS N/A
  • BCYC N/A
  • Revenue
  • VSTS $2,707,109,000.00
  • BCYC $28,339,000.00
  • Revenue This Year
  • VSTS N/A
  • BCYC N/A
  • Revenue Next Year
  • VSTS $0.29
  • BCYC N/A
  • P/E Ratio
  • VSTS N/A
  • BCYC N/A
  • Revenue Growth
  • VSTS N/A
  • BCYC N/A
  • 52 Week Low
  • VSTS $3.98
  • BCYC $6.10
  • 52 Week High
  • VSTS $17.83
  • BCYC $25.39
  • Technical
  • Relative Strength Index (RSI)
  • VSTS 59.96
  • BCYC 31.77
  • Support Level
  • VSTS $4.83
  • BCYC $7.65
  • Resistance Level
  • VSTS $5.30
  • BCYC $9.08
  • Average True Range (ATR)
  • VSTS 0.22
  • BCYC 0.57
  • MACD
  • VSTS -0.01
  • BCYC -0.22
  • Stochastic Oscillator
  • VSTS 83.97
  • BCYC 2.35

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: